Postmenopausal population is at increased risk of musculoskeletal impairments. Sarcopenia and osteoporosis are associated
with significant morbidity and social and health-care costs. These two conditions are uniquely linked with similarities in
pathophysiology and diagnosticmethods. Uniformdiagnostic criteria for sarcopenia are still evolving. Postmenopausal sarcopenia
and osteoporosis share many environmental risk- and preventive factors. Moreover, geriatric frailty syndrome may result from
interaction of osteoporosis and sarcopenia and may lead to increased mortality. The present paper reviews the factors in evolution
of postmenopausal sarcopenia and osteoporosis.
1.